« Back
Home /
Dorsomorphin (Compound C) dihydrochloride

Dorsomorphin (Compound C) dihydrochloride

Item no.	M2238-100mg
Manufacturer	AbMole
CASRN	1219168-18-9
Amount	100mg
Category	Oncology Neuroscience Metabolism Glucose Homeostasis Molecular Targets for Neuroscience Inhibitors & Compound Libraries Small Molecules By Organ Heart & Blood Cancer
Type	Inhibitors
Specific against	other
Purity	0,9967
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BML-275 2HCl; Compound C 2HCl
Similar products	Dorsomorphin dihydrochloride, BML-275
Available
Target Information	AMPK
Molecular Weight	472, 41
Solubility	Water 45 mg/mL; DMSO 5 mg/mL (Need ultrasonic)
Bioactivity information	Dorsomorphin (BML-275) dihydrochloride is a potent inhibitor of AMP-activated protein kinase (AMPK), with a Ki of 109 nM. Dorsomorphin dihydrochloride inhibits BMP pathway by targeting the type I receptors ALK2, ALK3, and ALK6. Dorsomorphin dihydrochloride induces autophagy.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M2238-100mg-safety-datasheet.pdf